Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0017636 (
glioblastoma
)
18,345
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
In a strategy to identify novel genes involved in glioma pathogenesis by molecular characterization of chromosomal translocation breakpoints, we identified the
KIAA1797
gene, encoding a protein with an as yet undefined function, to be disrupted by a 7;9 translocation in a primary
glioblastoma
culture. Array-based comparative genomic hybridization detected deletions involving
KIAA1797
in around half of
glioblastoma
cell lines and glioblastomas investigated. Quantification of messenger RNA levels in human tissues demonstrated highest
KIAA1797
expression in brain, reduced levels in all
glioblastoma
cell lines and most glioblastomas and similar levels in glial and neuronal cells by analysis of different hippocampal regions from murine brain. Antibodies against
KIAA1797
were generated and showed similar protein levels in cortex and subcortical white matter of human brain, while levels were significantly reduced in glioblastomas with
KIAA1797
deletion. By immunofluorescence of astrocytoma cells,
KIAA1797
co-localized with vinculin in focal adhesions. Physical interaction between
KIAA1797
and vinculin was demonstrated via co-immunoprecipitation. Functional in vitro assays demonstrated a significant decrease in colony formation, migration and invasion capacity of LN18 and U87MG glioma cells carrying a homozygous
KIAA1797
deletion ectopically expressing
KIAA1797
compared with mock-transduced cells. In an in vivo orthotopic xenograft mouse model, U87MG tumour lesions expressing
KIAA1797
had a significantly reduced volume compared to tumours not expressing
KIAA1797
. In summary, the frequently deleted
KIAA1797
gene encodes a novel focal adhesion complex protein with tumour suppressor function in gliomas, which we name 'focadhesin'. Since
KIAA1797
genetic variation has been implicated in Alzheimer's disease, our data are also relevant for neurodegeneration.
...
PMID:KIAA1797/FOCAD encodes a novel focal adhesion protein with tumour suppressor function in gliomas. 2242 31